A simeprevir-inducible molecular switch for the control of cell and gene therapies. [PDF]
Chin SE +12 more
europepmc +1 more source
Increasing competition in pharmaceutical tenders: Patents, treatment guidelines, and centralised procurement of Hepatitis C drugs in Brazil. [PDF]
Mercadante E.
europepmc +1 more source
Short-Term Clinical and Immunologic Outcomes Conditional on SVR12 in Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Treated With Direct-Acting Antivirals: A Systematic Review and Meta-Analysis. [PDF]
Boonpheng B, Ungprasert P.
europepmc +1 more source
Machine Learning and Molecular Modeling for Drug Repurposing Targeting Potential PI3Kα Inhibitors in Post-CoViD-19 Pulmonary Fibrosis. [PDF]
Dos Santos CR +4 more
europepmc +1 more source
Simeprevir: The First Macrocyclic Drug Elucidated Ab Initio by MicroED
Obtaining single crystal X-ray driffraction (XRD) structures of macrocylcic drugs has proven to be challenging. One of the major bottlenecks is growing sufficiently large crystals needed for XRD.
Bu, Guanhong +3 more
core
MicroED as a Powerful Tool for Structure Determination of Macrocyclic Drug Compounds Directly from Their Powder Formulations. [PDF]
Danelius E, Bu G, Wieske LHE, Gonen T.
europepmc +1 more source
Loss of KLF15 expression characterizes proximal tubule injury in cisplatin-induced acute kidney injury: A multi-omics study. [PDF]
Chen L +5 more
europepmc +1 more source
Molecular chameleons adaptability in target binding. [PDF]
Bu G, Eriksson M, Rova Danelius E.
europepmc +1 more source
An eco-friendly chemometrics assisted UV spectrophotometric method for simultaneous determination of sofosbuvir, simeprevir and ledipasvir in pharmaceuticals. [PDF]
Alshehri A +3 more
europepmc +1 more source
Repurposing of approved drugs towards Nipah virus treatment: an in silico docking, molecular dynamics simulation and a MM/GBSA approach. [PDF]
Hatimuria M +6 more
europepmc +1 more source

